Clinical and Cost Implications of Insulin Degludec in Patients with Type 1 Diabetes and Problematic Hypoglycemia: A Quality Improvement Project

INTRODUCTION: To assess the real-life clinical benefits and cost implications of switching from another basal insulin to insulin degludec (degludec) in patients with type 1 diabetes (T1D) on basal–bolus regimens with recurrent hypoglycemia and/or hypoglycemia unawareness. METHODS: Patients with T1D...

Descripción completa

Detalles Bibliográficos
Autores principales: Karamat, Muhammad Ali, Dar, Shujah, Bellary, Srikanth, Tahrani, Abd A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104283/
https://www.ncbi.nlm.nih.gov/pubmed/29549574
http://dx.doi.org/10.1007/s13300-018-0400-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104283/
https://www.ncbi.nlm.nih.gov/pubmed/29549574
http://dx.doi.org/10.1007/s13300-018-0400-x

Ejemplares similares